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Abstract
Objective: Differences between women and men in political and economic empowerment, education, and health risks are
well-documented. Similar gender inequities in access to care and medicines have been hypothesized but evidence is
lacking.
Methods: We analyzed 2002 World Health Survey data for 257,922 adult respondents and 80,932 children less than 5 years
old from 53 mostly low and middle-income countries. We constructed indicators of need for, access to, and perceptions of
care, and we described the number of countries with equal and statistically different proportions of women and men for
each indicator. Using multivariate logistic regression models, we estimated effects of gender on our study outcomes, overall
and by household poverty.
Findings: Women reported significantly more need for care for three of six chronic conditions surveyed, and they were
more likely to have at least one of the conditions (OR 1.41 [95% CI 1.38, 1.44]). Among those with reported need for care,
there were no consistent differences in access to care between women and men overall (e.g., treatment for all reported
chronic conditions, OR 1.00 [0.96, 1.04]) or by household poverty. Of concern, access to care for chronic conditions was
distressingly low among both men and women in many countries, as was access to preventive services among boys and
girls less than 5 years old.
Conclusions: These cross-country results do not suggest a systematic disadvantage of women in access to curative care and
medicines for treating selected chronic conditions or acute symptoms, or to preventive services among boys and girls.
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Background
Gender differences have become a key global concern.
Governments [1–3], the United Nation [4], and the World
Health Organization (WHO) [5] have established gender-focused
development programs which generally refer to gender equality,
i.e., equal representation of women and men, in government
bodies, leadership positions, and at educational levels. The WHO
has called for inclusion of a gender perspective in national essential
medicines programs [6]. Such a perspective implies moving
towards gender equity, that is, equal access to and use of medicines
for women and men who have similar needs, which vary by gender
and throughout the life course.
Increased risk of death among women from child birth, unsafe
abortion, gender-related violence, and sexually transmitted
diseases including HIV infection [7] and limited progress toward
achieving the gender-focused Millennium Development Goal
(MDG) 4, to reduce child mortality, and MDG 5, to improve
maternal health [8], are well documented. While researchers have
begun to focus on gender differences in care [9–14], almost no
empirical data exist to inform policy makers on the role of gender
in need for and access to medicines or on useful targets for gender
equity initiatives [15].
This research uses large-scale survey data to address the
following questions: Are there systematic gender differences in
need for and access to treatment for chronic and acute conditions
among adults; or in access to preventive or curative care among
children under 5 years old?
Methods
Ethics statement
The study was determined to be exempt from human subjects
review by the Human Studies Committee of Harvard Pilgrim
Health Care.
Data sources and measures
We used data from the World Health Survey (WHS) [16,17]
conducted by the WHO in 2002 and 2003 in 70 countries.
Detailed information on household and respondent selection, as
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using multi-stage cluster randomized sampling, country household
samples were drawn from nationally representative sample frames.
In the 53 study countries, household respondents, selected from all
eligible adult household members based on Kish tables [18],
completed the long version of the survey in face-to-face interviews
with trained interviewers. Country samples consisted of 668 to
38,614 households and 585 to 38,618 individuals, with high
household (median 89%; range 24%–100%) and individual
(median 98%, range 63%–100%) response rates across countries
[20].
The adult respondent answered mostly closed-ended questions
about health problems, care seeking, and care received for
themselves and for the youngest child under 5 years old in the
household; they also provided information about household
characteristics including assets, expenditures, and insurance
coverage of members. We have previously reported on household
access to care, burden of health care expenditures, and household
risk protection [21].
For the present analysis, we constructed indicators of need for
care; access to care and medicines; and perceptions of the health
care system.
Need for care
To describe adults’ need for health care and medicines, we assessed
reports of moderate, bad, or very bad health and moderate, severe,
or extreme limitations in daily activities; having ever been
diagnosed with or in the past 12 months experienced symptoms
of one or more of six chronic conditions (arthritis, angina, asthma,
depression, schizophrenia, and diabetes); and needing care in the
past year for acute symptoms (high fever, severe diarrhoea, cough).
The target chronic conditions included in the WHS were selected
due to a high global burden of disease and were assessed using
questions from established survey tools, where available [19,22].
We defined children’s need for care as the youngest child less than 5
years in the household having ever experienced fever, diarrhoea,
or another illness.
Access to care and medicines
For adult respondents, we defined access to care and medicines for a
chronic condition as having received medications or other treatments
during the past two weeks for the six target chronic conditions. For
those who reported need for acute care in the past year, we defined
overall access to acute care as receiving care when last needed for high
fever, severe diarrhoea, or cough and access to medicines as getting all
or most medicines prescribed during the last health care encounter
for conditions generally treatable with medicines (high fever,
severe diarrhoea, cough, arthritis, asthma, heart disease).
For children under 5 years, we defined access to care according to
specific measures in the WHS, namely having received: at least
one Vitamin A capsule in the past 12 months; one measles and at
least one diphtheria, tetanus, or whooping cough (DPT) vaccina-
tion; all three DPT vaccinations; or care for fever, diarrhoea, or
any other illness when last needed. We also defined access to malaria
treatment in children as having received any treatment for malaria
and an antimalarial prescribed by a medical professional during
the last episode of fever.
Perceptions of care
We defined several measures of respondents’ perceptions of care:
one indicator of satisfaction with ‘‘the way health care runs’’ in
their country and indicators of perceived discrimination based on
feelings of having been treated worse by outpatient health care
providers because of gender, type of illness, social class, or lack of
money.
Household and respondent characteristics
We characterized households and respondents according to
socioeconomic and demographic characteristics, including: house-
hold size greater than or equal to 6 members; having a household
member age 60 years and older and/or a child under 5 years;
highest education of any household member as none or less than
primary school; household wealth in the lowest two income
quintiles based on household assets (described as ‘‘poor’’); urban
location; coverage of household members (all, some, none) by
mandatory or voluntary health insurance; and respondent age
(18–29 years, 30–59 years, 60+ years), marital status, and
education (either no formal schooling or less than primary school).
Analysis
The WHS employed a complex survey design with differing
weights, stratification, and clustering in each country. Our
descriptive within-country analyses adjust for the survey design
where possible, using sample weights provided with the data. We
describe results for men and women respondents and for girls and
boys, both for all households and separately for poor households.
We used multi-country individual-level logistic regression
models (without country-level survey sampling weights) to explore
the relationships between gender and need for care, access to care
and medicines, and perceptions of care. To assess whether gender
effects differed by household poverty, we included gender and
poverty interaction terms in the models and estimated gender
effects among those in the lowest two income quintiles (‘‘poor’’)
versus the other three income quintiles (‘‘non-poor’’). We also used
robust variance estimation [23] to estimate gender effects when
logistic main effects models suggested gender differences, to
account for possible within-country correlations. Since results were
similar, we only report logistic regression estimates.
In all multivariate analyses, estimates of gender differences are
adjusted for the household and respondent characteristics listed
above. Since we selected household and respondent characteristics
on conceptual grounds, we did not apply variable elimination
strategies. We used SAS version 9.1 for the analyses and p,0.05 as
the significance threshold. Study data were provided in de-
identified country datasets by the WHO.
Results
We analyzed data from 257,922 adult respondents and 80,932
children less than 5 years old from 53 mostly low and middle
income countries [24] in East Asia and Pacific (n=6 countries; 3
low [LIC], 2 lower-middle [LMIC], and 1 upper-middle [UMIC]
income); Europe and Central Asia (n=14; 6 high-income
countries [HIC], 3 LMIC, 5 UMIC); Latin America and the
Caribbean (n=7; 4 LMIC, 3 UMIC); Middle East and North
Africa (n=3; 1 HIC, 2 LMIC); South Asia (n=5; 3 LIC, 2 LMIC);
and Sub-Saharan Africa (n=18; 13 LIC, 3 LMIC, 2 UMIC).
Country-level results are listed in Tables S1, S2, S3, S4, S5, S6,
S7, S8.
Respondent demographics
Table 1 describes respondent characteristics across countries.
The median proportions of women age 60 and older, with limited
schooling, and not working for pay were significantly higher than
the corresponding proportions of men. Figure 1 summarizes these
country-level data by displaying for each characteristic three
groups: the number of countries in which the percentage of
Medicines and Gender
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percentage of men; the number in which these percentages were
not significantly different; and the number of countries where the
percentage of men was significantly greater. In substantial
numbers of countries, significantly more women were older
(n=19 countries), less educated (n=34), and not working for
pay (n=42). Since age, education, and employment could
confound analyses of gender differences in need for and access
to care, we adjusted for differences in these respondent
demographic characteristics in multivariate analyses.
Need for care among adults
More than one-third of respondents rated their health as
moderate, bad, or very bad. The percentage of individuals
reporting chronic conditions varied across countries, but was
generally small (Tables S1, S2, S3, S4, S5, S6).
Across countries, larger proportions of women reported need for
care than men (Table 2). In more than 80% of countries,
significantly greater percentages of women reported lower health
status and greater limitations in daily activities than men (Figures 2-
1 and 2-2). Among the poor, differences between men and women
were fewer, but still significant in more than half of the countries.
In more than half of the countries, significantly greater
percentages of women reported diagnoses of arthritis, angina
(Figure 2), and depression (Figure 3); in about 20% of countries,
significantly greater percentages of women reported diagnoses of
asthma and diabetes (Figure 2). Among the poor, fewer countries
exhibited significant gender differences.
In multivariate analyses (Table 3), women were significantly
more likely than men to rate their health as poor (odds ratio 1.36,
95% confidence interval [1.33,1.38]), to report difficulties with
activities (1.21 [1.18,1.24]), to need care for acute symptoms (1.45
[1.39, 1.52]) and to have been diagnosed with or experienced
symptoms of at least one of six chronic conditions (1.41
[1.38,1.44]), arthritis (1.46 [1.43,1.50]), angina (1.37 [1.34,1.41]),
and depression (1.56 [1.51,1.60]).
Access to care among adults
Across countries, generally less than half of adults diagnosed
with a chronic condition reported receiving medication or other
treatments in the past 2 weeks (Table 2). Women and men with
chronic conditions reported similarly low rates of access to
medications and other treatments, both overall and among the
poor (Figures 2-1 and 2-2). In contrast, men and women both
reported very high rates of access to acute care when last needed
(greater than 95%), overall and among the poor (Table 2). In most
countries and for the poor, access to care when last needed and
access to prescribed medicines during the last health care
encounter did not differ significantly between women and men
(Figure 4).
In multivariate analyses, women with arthritis, asthma, and
depression reported receiving medication treatment for these
conditions significantly more frequently than men. The genders
did not differ significantly in access to medications for all chronic
conditions measured, or for angina, schizophrenia, and diabetes;
in access to acute care when last needed; or in access to prescribed
medicines during the last encounter (Table 4).
Of interest, women were significantly more likely to report
being satisfied with their country’s health care system than men.
There were no gender differences in perceptions of discrimination
in outpatient care due to gender; but women were significantly less
Figure 1. Adult demographics, number of countries with significant gender differences, all versus poor households.
doi:10.1371/journal.pone.0057228.g001
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illness, social class, or lack of money (Table 5).
Access to prevention, need for and access to care among
children
Rates of immunization and Vitamin A coverage varied greatly
across countries; of concern, in half of countries, only 50% or less
of children under 5 years old received at least one measles and
DPT vaccine or Vitamin A prophylaxis (Table 3). In most
countries, Vitamin A coverage, immunizations, access to care
when needed, and malaria treatment did not differ for girls and
boys in unadjusted (Figure 4) or multivariate (Table 6) analyses. In
multivariate analyses, girls were less likely to have reported illness
than boys (Table 6).
Gender and poverty
For all child and most adult care variables studied, the effect of
gender did not differ significantly by household poverty (Tables 3a
and 3c). For the few outcomes where gender – poverty interactions
Table 1. Median (interquartile range) of percentage of characteristics of adult respondents and their households in 53 countries.
Respondents from all households Respondents from poor households
Female, n=143238 Male, n=114684 Female, n=53155 Male, n=41810
Number of adults 2453 (1534, 2828) 1830 (1165, 2354) 860 (517, 1107) 677 (433, 919)
Age 18–29 years 35.3 (24.6, 39.9) 37.9 (26.1, 42.4) 35.6 (23.1, 39.2) 36.4 (22.2, 39.8)
Age 30–59 years 50.2 (48.0, 51.9) 50.8 (47.0, 53.4) 48.8 (42.5, 51.0) 49.7 (45.3, 52.4)
Age$60 years 12.4 (10.8, 20.7) 11.0 (9.3, 19.4) 13.7 (11.3, 24.4) 12.4 (9.8, 25.8)
Currently married 59.1 (50.1, 68.0) 60.6 (52.2, 69.9) 57.9 (46.1, 68.6) 61.6 (49.5, 71.0)
No schooling or less than
primary education
29.7 (12.6, 63.8) 24.0 (10.2, 47.8) 45.7 (20.2, 83.8) 35.7 (21.0, 69.9)
Not working for pay 62.7 (49.6, 68.7) 28.4 (18.3, 39.6) 68.3 (56.5, 76.0) 29.4 (13.9, 52.7)
doi:10.1371/journal.pone.0057228.t001
Figure 2. Chronic conditions among adults, number of countries with significant gender differences, all versus poor households.
Chronic conditions (arthritis, angina, asthma, diabetes) among adults, number of countries with significant gender differences, all versus poor
households.
doi:10.1371/journal.pone.0057228.g002
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Respondents from all households Respondents from poor households
Female, n=143238 Male, n=114684 Female, n=53155 Male, n=41810
Number of adults per country 2453 (1534, 2828) 1830 (1165, 2354) 860 (517, 1107) 677 (433, 919)
Need for care
Self-rated health moderate, bad, very bad 45.0 (31.7, 49.6) 33.9 (22.4, 39.6) 47.2 (36.4, 61.8) 39.5 (27.8, 47.4)
Moderate, severe or extreme difficulty with work or household activities 27.4 (19.3, 33.8) 20.2 (14.1, 26.7) 33.1 (22.4, 41.0) 25.5 (16.8, 34.6)
Arthritis: ever diagnosed 15.2 (10.3, 20.4) 9.7 (5.6, 13.7) 17.2 (11.1,23.1) 10.7 (6.7, 16.8)
Angina: ever diagnosed 6.8 (4.9, 11.6) 5.3 (3.1, 8.1) 8.1 (4.7, 13.7) 6.4 (3.3, 10.4)
Asthma: ever diagnosed 4.7 (3.4, 6.5) 3.9 (2.7, 5.2) 5.3 (3.5, 6.6) 3.7 (2.4, 6.1)
Depression: ever diagnosed 5.0 (2.2, 9.2) 2.9 (1.4, 4.6) 4.8 (2.0, 9.8) 2.6 (1.4, 5.0)
Schizophrenia: ever diagnosed 0.8 (0.4, 1.5) 0.8 (0.4, 1.3) 0.9 (0.5, 1.8) 1.0 (0.6, 1.7)
Diabetes: ever diagnosed 2.9 (1.1, 5.5) 2.2 (1.1, 3.8) 2.5 (0.8, 5.0) 1.4 (0.6, 2.6)
Access to care among those with need for care
Arthritis treatment in last 2 weeks 42.6 (28.9, 49.9) 34.9 (27.0, 44.9) 39.0 (24.1, 51.3) 32.9 (21.5, 45.9)
Angina treatment in last 2 weeks 37.6 (26.4, 62.4) 46.3 (29.2, 60.4) 33.1 (22.8, 64.5) 38.3 (21.9, 61.0)
Asthma treatment in last 2 weeks 42.6 (34.5, 54.8) 41.1 (30.2, 54.4) 38.9 (31.9, 57.5) 44.4 (23.0, 51.9)
Depression treatment in last 2 weeks 30.5 (23.4, 38.0) 27.9 (17.2, 43.7) 29.6 (15.1, 42.0) 28.1 (13.5, 44.9)
Schizophrenia treatment in last 2 weeks 34.7 (22.5, 57.2) 40.8 (27.6, 51.9) 33.2 (14.9, 61.4) 35.6 (21.9, 60.6)
Diabetes treatment in last 2 weeks 53.9 (37.8, 64.0) 54.6 (42.8, 69.3) 48.2 (25.8, 62.2) 47.8 (23.4, 72.9)
Received acute care when needed in past year 96.4 (93.1, 98.6) 95.9 (92.6, 99.2) 95.9 (87.3, 99.5) 94.1 (88.6, 99.1)
Received all or most medicines prescribed during last visit 75.7 (67.5, 84.0) 77.8 (65.8, 82.5) 71.4 (63.1, 80.9) 72.6 (62.5, 83.4)
doi:10.1371/journal.pone.0057228.t002
Figure 3. Chronic conditions among adults, number of countries with significant gender differences, all versus poor households.
Chronic conditions among adults (activity limitations, self-reported health, depression, schizophrenia), number of countries with significant gender
differences, all versus poor households.
doi:10.1371/journal.pone.0057228.g003
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depression; diagnosis of diabetes; treatment for chronic conditions;
and treatment for angina), there was no clear pattern of gender
differences among poor versus non-poor households. Women in
poor households were more likely than men to report difficulty
with daily activities and depression; this difference was lower in
non-poor households. Women in poor households reported more
diabetes diagnoses and marginally more treatment for all chronic
conditions, while there were no significant differences in less poor
households. Women in non-poor households reported lower rates
of angina treatment, while there were no significant differences
between women and men in poor households (Table 4).
Discussion
In light of well-known gender gaps in health, education,
economic participation and opportunity, and political empower-
ment [25], some have expressed concerns that women may also
have less access to health care and medicines than men [6,15].
Table 3. Median (interquartile range) of percentage of children under 5 years old with access to prevention, need for and access
to curative care in 53 countries.
Children from all households Children from poor households
Female, n=39640 Male, n=41292 Female, n=16506 Male, n=17152
Number of children 601 (202, 948) 651 (202, 999) 256 (72, 407) 265 (74, 400)
At least one Vitamin A capsule in past 12 months 57.1 (30.6, 76.3) 55.3 (30.7, 73.3) 52.9 (26.0, 75.0) 55.1 (27.9, 69.2)
At least measles and one DPT vaccine received 39.2 (27.0, 58.4) 39.6 (26.8, 58.7) 36.8 (21.9, 58.5) 40.4 (26.1, 58.5)
Fever, diarrhoea, or other illness within last month 37.7 (27.8, 45.4) 38.6 (29.1, 45.9) 37.7 (24.3, 44.3) 39.0 (31.3, 47.5)
Care received for last illness 87.4 (80.2, 91.8) 85.8 (79.2, 90.7) 83.7 (73.9, 90.7) 82.2 (75.2, 88.3)
Care received in hospital 24.8 (16.3, 41.5) 27.5 (16.6, 43.4) 24.3 (14.3, 37.2) 33.3 (20.1, 49.5)
Care received in public facility 85.9 (75.7, 93.6) 86.5 (71.1, 93.3) 90.5 (79.6, 96.2) 92.1 (80.5, 98.7)
Treatment for malaria during last episode of fever 47.7 (9.2, 79.1) 48.8 (11.0, 77.9) 46.1 (11.3, 75.4) 45.3 (11.5, 77.5)
Anti-malarial prescribed by professional for fever
treated for malaria
98.2 (90.3, 100.0) 97.5 (93.5, 100.0) 98.9 (87.7, 100.0) 97.1 (86.5, 100.0)
doi:10.1371/journal.pone.0057228.t003
Figure 4. Access to care, number of countries with significant gender differences, all versus poor households.
doi:10.1371/journal.pone.0057228.g004
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and children from 53 countries in six regions, our results suggest
that women in many countries report significantly more need for
health care and medicines than men. However, contrary to
expectations, we did not find consistent differences across
countries in indicators of access to treatment between women
Table 4. Relationship of gender to need for, access to care among adult respondents*.
Odds ratio, all households
(95% confidence interval)
Odds ratio, poor
households (95%
confidence interval)
Odds ratio, less poor
households (95%
confidence interval)
Need for care
Self-rated health moderate, bad, very bad 1.36 (1.33, 1.38) 1.37 (1.33, 1.41) 1.35 (1.31, 1.38)
Moderate, severe or extreme difficulty with work or
household activities
1.21 (1.18, 1.24) 1.14 (1.10, 1.18)
# 1.27 (1.23, 1.31)
#
At least one chronic condition 1.41 (1.38, 1.44) 1.40 (1.36, 1.44) 1.42 (1.38, 1.45)
Arthritis diagnosis or symptoms 1.46 (1.43, 1.50) 1.42 (1.37, 1.47) 1.49 (1.44, 1.54)
Angina diagnosis or symptoms 1.37 (1.34, 1.41) 1.38 (1.33, 1.43) 1.37 (1.32, 1.42)
Asthma diagnosis or symptoms 1.01 (0.98, 1.04) 0.98 (0.94, 1.03) 1.03 (0.99, 1.07)
Depression diagnosis or symptoms 1.56 (1.51, 1.60) 1.48 (1.41, 1.55)
# 1.62 (1.55, 1.68)
#
Schizophrenia diagnosis 1.01 (0.92, 1.09) 1.06 (0.93, 1.20) 0.96 (0.86, 1.08)
Diabetes diagnosis 1.05 (1.00, 1.11) 1.25 (1.14, 1.36)
# 0.96 (0.90, 1.02)
#
Needed acute care within past year 1.45 (1.39, 1.52) 1.42 (1.32, 1.53) 1.47 (1.39, 1.56)
Access to care and medicines
Treatment for all reported chronic conditions 1.00 (0.96, 1.04) 1.08 (1.01, 1.15)
# 0.95 (0.90, 1.00)
#
Arthritis treatment 1.22 (1.16, 1.28) 1.27 (1.18, 1.38) 1.18 (1.10, 1.26)
Angina treatment 0.95 (0.90, 1.02) 1.04 (0.94, 1.14)
# 0.90 (0.82, 0.97)
#
Asthma treatment 1.19 (1.11, 1.28) 1.21 (1.09, 1.35) 1.17 (1.07, 1.29)
Depression treatment 1.18 (1.08, 1.29) 1.24 (1.08, 1.43) 1.14 (1.02, 1.28)
Schizophrenia treatment 0.94 (0.78, 1.13) 0.93 (0.70, 1.23) 0.95 (0.73, 1.23)
Diabetes treatment 1.01 (0.91, 1.12) 1.11 (0.93, 1.32) 0.96 (0.85, 1.09)
Acute care when needed in past year 0.95 (0.85, 1.06) 0.86 (0.73, 1.00) 1.04 (0.90, 1.21)
All or most medicines needed during last visit 0.98 (0.93, 1.03) 0.97 (0.89, 1.05) 0.99 (0.92, 1.06)
*Females are coded as 1 in the models. Models control for household size; having a member age 60 years and older or a child under 5 years (adult models only); highest
education of any household member; household poverty; urban location; insurance coverage; respondent age, marital status, education, and health status. Access to
care models are for populations with need for care.
#Indicates that odds ratios among poor and non-poor differ significantly (p,0.05).
doi:10.1371/journal.pone.0057228.t004
Table 5. Relationship of gender to perceptions of care among adult respondents*.
Odds ratio, all households (95%
confidence interval)
Odds ratio, poor households (95%
confidence interval)
Odds ratio, less poor households
(95% confidence interval)
Perceptions of care
High satisfaction with health care in
country
1.15 (1.13, 1.17) 1.14 (1.11, 1.17) 1.15 (1.13, 1.18)
Perceived discrimination in outpatient
care due to gender
1.00 (0.88, 1.14) 1.12 (0.90, 1.40) 0.94 (0.80, 1.11)
Perceived discrimination in outpatient
care due to illness
0.85 (0.75, 0.96) 0.80 (0.66, 0.98) 0.87 (0.75, 1.02)
Perceived discrimination in outpatient
care due to social class
0.88 (0.81, 0.94) 0.82 (0.73, 0.91) 0.92 (0.84, 1.01)
Perceived discrimination in outpatient
care due to lack of money
0.88 (0.83, 0.93) 0.85 (0.78, 0.93) 0.90 (0.84, 0.97)
*Females are coded as 1 in the models. Models control for household size; having a member age 60 years and older or a child under 5 years (adult models only); highest
education of any household member; household poverty; urban location; insurance coverage; respondent age, marital status, education, and health status. Access to
care models are for populations with need for care.
#Indicates that odds ratios among poor and non-poor differ significantly (p,0.05).
doi:10.1371/journal.pone.0057228.t005
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differences in selected indicators of access to preventive or curative
care for children. In addition, gender and care relationships
among poor households were similar to those among non-poor
households. Thus, although situations in individual countries [26]
will likely differ, our aggregated analyses do not support the notion
of uniform gender inequity in access to health care or medicines
for the selected conditions measured in the WHS.
How can we explain the discrepancy between our findings and
prior expectations of gender inequities disadvantaging women?
First, adult respondents to the WHS were a heterogeneous group
both within and across countries in terms of health needs, access to
care, and their determinants; thus, noise could have masked
statistical relationships between gender and access to care. Further,
relatively few respondents reported chronic conditions, which may
in part be due to self-reported ascertainment of these conditions in
the WHS. Given self-reported need for chronic care, relatively few
respondents reported having access to care. Similarly, in some
countries, larger than expected proportions of children under 5
years of age were reported to not have been sick. Thus, samples
could have been too small to detect significant gender differences.
However, given the overall large WHS sample sizes and number
of countries, we would expect to see consistent trends emerge to
support evidence of gender inequity, either overall or among the
poor; yet our analyses do not show such trends. In addition, we
cannot exclude differential reporting of symptoms, diagnoses, or
treatments between men and women; given the heterogeneity of
cultures represented in the survey, such differences may have
biased our results toward the Null.
We did not examine areas of widely-reported health disadvan-
tages for women, such as physical and sexual violence, sexually
transmitted diseases, HIV/AIDS, or pregnancy and child birth
and cannot comment on possible inequity in access to care for
these health needs or on the social factors that might increase
women’s health risks [27].
Our findings that women report equal or greater prevalence of
common health problems and equal access to needed care is
consistent with evidence from a number of recent studies,
including a report on management of diabetes and cardiovascular
risk factors in seven countries [28]; a study of prescribing patterns
for men and women with diabetes in Bahrain [29]; one that
demonstrated higher age-adjusted prevalence of medicines use
among women in Spain [30]; reports of more frequent and earlier
access to anti-retroviral treatment among women in countries in
Africa, Latin America, and Asia [12,31,32]; a UNICEF report
[33] showing that treatment for childhood pneumonia, diarrhoea,
and malaria does not vary by gender, and studies showing equal
access to care for boys and girls in Bangladesh and Tanzania
[34,35].
Several factors may increase rates of diagnoses and access to
care among women. Women have more frequent interactions with
the health care system, both because of reproductive health needs
and because they serve as family caregivers. They may thus have
more opportunity for diagnosis and treatment of the types of acute
and chronic conditions we studied. In addition, female community
health care workers may facilitate access to care for women [36]
and men may be more reluctant to seek care for cultural and other
reasons [37,38].
Importantly, the low reported levels of chronic and preventive
care for both women and men are disconcerting. For example, in
10 of 52 countries with sufficient data, less than a third of adults
with diagnosed diabetes reported treatment. With the prevalence
of chronic conditions increasing, health system interventions to
enable affordable access to long-term therapy are urgently needed
[39]. In 13 of 39 countries, less than a third of children had
received Vitamin A prophylaxis in the past year and in 20 of 50
countries, less than a third had received measles and or one DPT
vaccine. These results attest to the global need for effective health
system interventions to improve child survival [8].
Table 6. Relationship of gender to prevention and need for and access to curative care among children ,5 years old*.
Prevention, need for and
access to care
Odds ratio, all households
(95% confidence interval)
Odds ratio, poor households
(95% confidence interval)
Odds ratio, less poor
households (95% confidence
interval)
At least one Vitamin A capsule in
past 12 months
1.03 (1.00, 1.07) 1.04 (0.99, 1.09) 1.03 (0.98, 1.07)
Measles vaccine received 1.00 (0.98, 1.03) 1.01 (0.96, 1.05) 1.00 (0.96, 1.04)
At least one measles and one DPT
vaccine received
1.01 (0.98, 1.04) 1.01 (0.96, 1.05) 1.01 (0.97, 1.05)
All three DPT vaccines received 1.02 (0.99, 1.05) 1.02 (0.97, 1.06) 1.02 (0.98, 1.06)
Fever, severe diarrhoea, or other illness 0.93 (0.90, 0.97) 0.96 (0.92, 1.01) 0.91 (0.87, 0.95)
Malaria episode in past 12 months 1.05 (0.99, 1.12) 1.00 (0.91, 1.09) 1.09 (1.01, 1.18)
Care received for last illness 0.98 (0.94, 1.03) 1.01 (0.95, 1.07) 0.96 (0.9, 1.03)
Care received within 24 hours 1.00 (0.96, 1.04) 0.95 (0.90, 1.01) 1.03 (0.98, 1.09)
Care received in hospital 0.97 (0.94, 1.02) 0.94 (0.88, 1.00) 1.00 (0.95, 1.05)
Care received in public facility 1.05 (0.99, 1.11) 0.98 (0.88, 1.09) 1.08 (1.01, 1.17)
Treatment for malaria during last
episode of fever
1.01 (0.96, 1.06) 0.97 (0.89, 1.05) 1.05 (0.98, 1.13)
Anti-malarial prescribed by professional
for malaria
0.92 (0.75, 1.13) 0.79 (0.58, 1.09) 1.00 (0.76, 1.32)
*Females are coded as 1 in the models. Models control for household size; having a member age 60 years and older; highest education of any household member;
household poverty; urban location; insurance coverage; adult respondent age, marital status, education, and health status. Access to care models are for populations
with need for care.
doi:10.1371/journal.pone.0057228.t006
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utilize the same providers or receive the same quality of health
care. Gender-stratified assessment of the management of chronic
conditions in seven countries seemed to indicate more ineffective
management of blood glucose, blood pressure, and hypercholes-
terolemia among women with diabetes in four low and middle
income countries [28]; others found no gender difference in
quality of malaria case management [40].
We also do not know whether women and men faced similar
circumstances when negotiating access to care within households
and health care systems, or experienced the same economic
consequences of accessing care. Given that women generally have
less power and are poorer than men [41], they may have to
expend more effort to access care and experience greater
economic repercussions. However, notably, women reported more
satisfaction than men with their health care systems and did not
feel that they were treated worse than men because of their
gender.
The WHO has called for increased attention to gender and
poverty in health research [42]. Data on gender are typically
available in facility-level and community-level studies of medicines
access and use [43], but gender differences have rarely been the
focus of empirical analyses. Reporting results of such studies by
gender would provide evidence about the generalizability of these
finding in different settings, for other health problems, and over
time.
More empirical studies are needed to provide evidence about
the interrelationships of gender, poverty, and access to health care
and medicines, while social and behavioural studies are needed to
understand reasons for differences where they exist, negative
impacts on health, and potential mechanisms to redress them.
These interrelationships are likely to differ by culture, geography,
health system structure, and extent of social protection. Given the
dearth of empirical literature, we need studies in a wider variety of
settings to begin to disentangle the distinct roles of poverty and
gender in determining perceptions of illness, patterns of care
seeking, access to services, quality of the care, clinical effectiveness,
economic impacts, and consumer satisfaction. Documenting
specific gender differences in medicines access, use, and afford-
ability would highlight key policy issues and potential solutions to
achieve gender equity.
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